Picture of Corline Biomedical AB logo

CLBIO — Corline Biomedical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: European Patent Office To Approve Corline Biomedical's Renaparin Patents

June 17 (Reuters) - Corline Biomedical AB  CLBIO.ST :
    * EUROPEAN PATENT OFFICE INTENDS TO APPROVE ADDITIONAL
RENAPARIN
PATENTS
    * INTENT TO GRANT LETTER RECEIVED FROM THE EUROPEAN PATENT
OFFICE
TO GRANT THE COMPANY PATENT APPLICATION P9346EP1
    * PATENT APPLICATION COVERS CORLINE'S TECHNOLOGY TO PROCESS
AND
PROTECT BLOOD VESSELS IN ORGANS FOR TRANSPLANTATION AND IN THE
DIRECT TREATMENT OF PATIENT

Source text for Eikon:  ID:nGNE3tqbh1 
Further company coverage:  CLBIO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Corline Biomedical AB

See all news